Clarus Therapeutics Holdings, Inc. (CRXT): Price and Financial Metrics

Clarus Therapeutics Holdings, Inc. (CRXT): $0.05

0.02 (-31.16%)

POWR Rating

Component Grades








Add CRXT to Watchlist
Sign Up

CRXT Price/Volume Stats

Current price $0.05 52-week high $10.57
Prev. close $0.07 52-week low $0.05
Day low $0.05 Volume 2,737,100
Day high $0.07 Avg. volume 6,391,756
50-day MA $0.29 Dividend yield N/A
200-day MA $1.30 Market Cap 2.47M

CRXT Stock Price Chart Interactive Chart >

Clarus Therapeutics Holdings, Inc. (CRXT) Company Bio

Clarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.

CRXT Latest News Stream

Event/Time News Detail
Loading, please wait...

CRXT Latest Social Stream

Loading social stream, please wait...

View Full CRXT Social Stream

Latest CRXT News From Around the Web

Below are the latest news stories about CLARUS THERAPEUTICS HOLDINGS INC that investors may wish to consider to help them evaluate CRXT as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news on Tuesday morning.

William White on InvestorPlace | August 30, 2022

Dear AMC Stock Fans, Mark Your Calendars for Sept. 3

Fans of AMC Entertainment (AMC) stock will want to keep an eye on the company come Sept. 3 as it prepares for a special theater event.

William White on InvestorPlace | August 29, 2022

Why Is Humanigen (HGEN) Stock Down 16% Today?

Humanigen (HGEN) stock is heading lower on Monday as investors react to a minimum price delisting notice from the Nasdaq Exchange.

William White on InvestorPlace | August 29, 2022

Why Is Pinduoduo (PDD) Stock Up 18% Today?

Pinduoduo (PDD) stock is getting a boost on Monday after the Chinese agriculture tech company released results for Q2 2022.

William White on InvestorPlace | August 29, 2022

Clarus Therapeutics (CRXT) Stock Plunges Ahead of Aug. 31 Delisting

Clarus Therapeutics (CRXT) stock is falling hard on Monday as investors prepare for the stock to be delisted later this week.

William White on InvestorPlace | August 29, 2022

Read More 'CRXT' Stories Here

CRXT Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -99.50%
5-year N/A
2023 N/A
2022 0.00%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!